Longitudinal study of chronic wounds using novel measurement tech v01

  • Research type

    Research Study

  • Full title

    Longitudinal study of chronic wounds using novel wound measurement technologies

  • IRAS ID

    217442

  • Contact name

    Martin Johns

  • Contact email

    martin.johns@vivosight.com

  • Sponsor organisation

    Michelson Diagnostics Ltd

  • Clinicaltrials.gov Identifier

    NCT02967900

  • Duration of Study in the UK

    0 years, 12 months, 1 days

  • Research summary

    Diabetic foot ulcers (DFU) are very common, difficult to heal and impose an enormous burden on our health care system. One reason for poor healing is inadequate blood circulation at the wound edge. Currently our examination of wound edges is clinical. A novel innovation, VivoSight permits clear visualization of the small blood vessels that supply skin. The VivoSight probe noninvasively detects reflections from within skin illuminated using a low power infra-red laser. The device has been tested and found accurate in laboratory conditions, on normal skin, and at wound edges. Using this device we will noninvasively examine the number, shape of blood vessels very close to the skin which are responsible for delivering blood supply to wound edges. This study offers an excellent opportunity to test this optical microscopic device at wound edges to better understand its potential to predict wound healing.

    An open, non-randomised longitudinal study of diabetic foot ulcers receiving standardised treatment, over a 16 week period conducted at out-patient level.

  • REC name

    North West - Greater Manchester Central Research Ethics Committee

  • REC reference

    17/NW/0145

  • Date of REC Opinion

    7 Apr 2017

  • REC opinion

    Further Information Favourable Opinion